- Home
- Publications
- Publication Search
- Publication Details
Title
Etanercept: efficacy and safety for approved indications
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 11, Issue 1, Pages 121-139
Publisher
Informa Healthcare
Online
2011-11-11
DOI
10.1517/14740338.2012.633509
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and Efficacy of Etanercept in Children with Juvenile-Onset Behcet's Disease
- (2017) L. Cantarini et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks
- (2011) T. Gambichler et al. BRITISH JOURNAL OF DERMATOLOGY
- TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists
- (2011) Victoria L. Williams et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
- (2010) D. Vassilopoulos et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
- (2010) I. Garcia-Doval et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
- (2010) D. Salmon-Ceron et al. ANNALS OF THE RHEUMATIC DISEASES
- Is Etanercept Safe for Treating Plaque Psoriasis in a Patient With Chronic Hepatitis C Virus Infection?
- (2010) Rishi K. Gandhi et al. ARCHIVES OF DERMATOLOGY
- Tumor necrosis factor α blockers and malignancy in children: Forty-eight cases reported to the food and drug administration
- (2010) Peter Diak et al. ARTHRITIS AND RHEUMATISM
- Is antitumour necrosis factor therapy combined with ultraviolet B phototherapy safe?
- (2010) V. Di Lernia et al. BRITISH JOURNAL OF DERMATOLOGY
- Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993–2007
- (2010) B.A. Reichgelt et al. EUROPEAN JOURNAL OF CANCER
- Biologics in children’s autoimmune disorders: efficacy and safety
- (2010) Luciana Breda et al. EUROPEAN JOURNAL OF PEDIATRICS
- Combination systemic therapies in psoriatic arthritis
- (2010) Meaghan Daly et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- New-onset psoriasis associated with etanercept therapy
- (2010) Lu-An CHEN et al. JOURNAL OF DERMATOLOGY
- Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-α antagonists
- (2010) Amer Alshekhlee et al. MUSCLE & NERVE
- Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
- (2010) Randy Q Cron et al. Pediatric Rheumatology
- Summary of worldwide pediatric malignancies reported after exposure to etanercept
- (2010) Peter McCroskery et al. Pediatric Rheumatology
- Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients
- (2010) Aikaterini Arida et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum
- (2009) A Murashima et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy
- (2009) Pierre Lozeron et al. ARCHIVES OF NEUROLOGY
- Etanercept-induced pleuropericardial lupus-like syndrome
- (2009) I. Porfyridis et al. EUROPEAN RESPIRATORY JOURNAL
- Treatment of neuro-Behçet’s disease: an update
- (2009) Afshin Borhani Haghighi Expert Review of Neurotherapeutics
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inflammatory Bowel Disease, Clinical
- (2009) JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Safety of Etanercept in Patients at High Risk for Mycobacterial Tuberculosis Infections
- (2009) R. AGGARWAL et al. JOURNAL OF RHEUMATOLOGY
- Use of Tumor Necrosis Factor- -blocking Agents in Hepatitis B Virus-positive Patients: Reports of 3 Cases and Review of the Literature
- (2009) S. ZINGARELLI et al. JOURNAL OF RHEUMATOLOGY
- Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis
- (2009) B. DIJKMANS et al. JOURNAL OF RHEUMATOLOGY
- Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation
- (2009) Amylynne J. Frankel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- DisseminatedHistoplasma capsulatuminfection presenting with panniculitis and focal myositis in rheumatoid arthritis treated with etanercept
- (2009) J. Bourré‐Tessier et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis
- (2009) Kristen Hayward et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
- (2008) B Combe et al. ANNALS OF THE RHEUMATIC DISEASES
- Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis
- (2008) A Spadaro et al. ANNALS OF THE RHEUMATIC DISEASES
- Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register
- (2008) M J Harrison et al. ANNALS OF THE RHEUMATIC DISEASES
- The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study
- (2008) Marte Schrumpf Heiberg et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
- (2008) Daniel J. Lovell et al. ARTHRITIS AND RHEUMATISM
- Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept
- (2008) P. Wolf et al. BRITISH JOURNAL OF DERMATOLOGY
- Ophthalmic manifestations of demyelination secondary to etanercept
- (2008) CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Efficacy of etanercept in the treatment of a patient with Behçet’s disease
- (2008) Valentina Curigliano et al. CLINICAL RHEUMATOLOGY
- Inflammatory demyelinating events following treatment with anti-tumor necrosis factor
- (2008) A. Fromont et al. CYTOKINE
- A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
- (2008) Nicholas C. Boetticher et al. GASTROENTEROLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2008) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Etanercept as a rescue agent in patient with adult onset Still’s disease complicated with congestive heart failure
- (2008) Deng-Ho Yang et al. RHEUMATOLOGY INTERNATIONAL
- Multiple sclerosis following etanercept treatment for ankylosing spondylitis
- (2008) C. F. Pfueller et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- The effect of weight on the efficacy of biologic therapy in patients with psoriasis
- (2007) Lily Clark et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started